Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKinsey
Merck
Johnson and Johnson
AstraZeneca

Last Updated: January 19, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ROFLUMILAST

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for Roflumilast

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00062582 Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110) Completed AstraZeneca Phase 3 2003-06-01 The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.
NCT00073177 Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012) Completed AstraZeneca Phase 3 2003-11-01 The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.
NCT00076076 The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023) Completed AstraZeneca Phase 3 2003-12-01 The purpose of this study is to confirm the dose of roflumilast to be used for asthma management by comparing the effects of 250 mcg and 500 mcg oral roflumilast with placebo on pulmonary function and asthma symptoms.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Roflumilast

Condition Name

Condition Name for Roflumilast
Intervention Trials
Chronic Obstructive Pulmonary Disease 14
COPD 13
Chronic Obstructive Pulmonary Disease (COPD) 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Roflumilast
Intervention Trials
Pulmonary Disease, Chronic Obstructive 33
Lung Diseases 31
Lung Diseases, Obstructive 29
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Roflumilast

Trials by Country

Trials by Country for Roflumilast
Location Trials
United States 303
Canada 20
Germany 12
Spain 12
United Kingdom 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Roflumilast
Location Trials
California 12
Texas 11
Pennsylvania 10
New York 10
Maryland 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Roflumilast

Clinical Trial Phase

Clinical Trial Phase for Roflumilast
Clinical Trial Phase Trials
Phase 4 11
Phase 3 22
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Roflumilast
Clinical Trial Phase Trials
Completed 45
Recruiting 11
Not yet recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Roflumilast

Sponsor Name

Sponsor Name for Roflumilast
Sponsor Trials
AstraZeneca 27
Takeda 11
Mitsubishi Tanabe Pharma Corporation 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Roflumilast
Sponsor Trials
Industry 53
Other 36
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Dow
AstraZeneca
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.